20 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Aerpio Pharmaceuticals, Inc. ARPO shares moved upwards by 74.85% to $1.09 during Wednesday's pre-market session.

• Edap TMS, Inc. EDAP stock moved upwards by 27.85% to $2.80. The most recent rating by B. Riley, on Apr 15, is at Buy, with a price target of $6.

• Genocea Biosciences, Inc. GNCA shares rose 21.85% to $3.29.

• Progyny, Inc. PGNY shares moved upwards by 16.64% to $23.90. The most recent rating by Citigroup, on Mar 10, is at Buy, with a price target of $29.

• Alcon, Inc. ALC stock rose 11.79% to $59.55. The most recent rating by Wells Fargo, on Apr 9, is at Overweight, with a price target of $58.

• Organovo Holdings, Inc. ONVO stock rose 11.47% to $0.82.

• Adamis Pharmaceuticals, Inc. ADMP shares increased by 11.15% to $0.58.

• Capricor Therapeutics, Inc. CAPR shares increased by 11.14% to $8.78.

• Forward Pharma, Inc. FWP stock moved upwards by 10.10% to $8.50.

• Veru, Inc. VERU shares moved upwards by 9.35% to $3.86.

Losers

• KemPharm, Inc. KMPH shares declined 13.70% to $0.25 during Wednesday's pre-market session.

• Phio Pharmaceuticals, Inc. PHIO shares declined 10.53% to $2.21.

• Adaptive Biotechnologies, Inc. ADPT stock fell 9.62% to $34.40.

• Baudax Bio, Inc. BXRX shares decreased by 9.43% to $3.17. The most recent rating by Oppenheimer, on May 11, is at Outperform, with a price target of $14.

• bluebird bio, Inc. BLUE stock decreased by 6.79% to $53. The most recent rating by RBC Capital, on May 13, is at Outperform, with a price target of $100.

• Outlook Therapeutics, Inc. OTLK stock decreased by 6.10% to $0.77.

• Acer Therapeutics, Inc. ACER stock fell 5.87% to $3.53.

• Helius Medical, Inc. HSDT shares fell 5.69% to $0.61.

• Eiger BioPharmaceuticals, Inc. EIGR shares decreased by 5% to $11.41. The most recent rating by Wedbush, on Apr 3, is at Outperform, with a price target of $33.

• ObsEva, Inc. OBSV shares decreased by 4.76% to $3.40. The most recent rating by HC Wainwright & Co., on Mar 23, is at Buy, with a price target of $36.